+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cystic Fibrosis Market Research Report by Route of Administration (Inhaled Drugs and Oral Drugs), Drug Class, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4829814
  • Report
  • April 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AbbVie Inc.
  • AlgiPharma AS
  • Allergan plc
  • AstraZeneca plc
  • Celtaxsys, Inc.
  • Elucigene Diagnostics
The Global Cystic Fibrosis Market size was estimated at USD 4,924.99 million in 2021, USD 5,380.55 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.42% to reach USD 8,455.74 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cystic Fibrosis to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Route of Administration, the market was studied across Inhaled Drugs and Oral Drugs.
  • Based on Drug Class, the market was studied across Bronchodilators, CFTR Modulators, Mucolytics, and Pancreatic Enzyme Supplements.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cystic Fibrosis market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cystic Fibrosis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cystic Fibrosis Market, including AbbVie Inc., Advanced Inhalation Therapies (AIT) Ltd., Alcresta Therapeutics, Inc., AlgiPharma AS, Allergan plc, AstraZeneca plc, Celtaxsys, Inc., Elucigene Diagnostics, F. Hoffmann-La Roche AG, Galapagos NV, Gilead Sciences, Inc., NovaBiotics Ltd, Novartis International AG, Teva Pharmaceutical Industries Ltd, and Vertex Pharmaceuticals, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cystic Fibrosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cystic Fibrosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cystic Fibrosis Market?
4. What is the competitive strategic window for opportunities in the Global Cystic Fibrosis Market?
5. What are the technology trends and regulatory frameworks in the Global Cystic Fibrosis Market?
6. What is the market share of the leading vendors in the Global Cystic Fibrosis Market?
7. What modes and strategic moves are considered suitable for entering the Global Cystic Fibrosis Market?
Frequently Asked Questions about the Global Cystic Fibrosis Market

What is the estimated value of the Global Cystic Fibrosis Market?

The Global Cystic Fibrosis Market was estimated to be valued at $4925.0 Million in 2021.

What is the growth rate of the Global Cystic Fibrosis Market?

The growth rate of the Global Cystic Fibrosis Market is 9.4%, with an estimated value of $8455.7 Million by 2027.

What is the forecasted size of the Global Cystic Fibrosis Market?

The Global Cystic Fibrosis Market is estimated to be worth $8455.7 Million by 2027.

Who are the key companies in the Global Cystic Fibrosis Market?

Key companies in the Global Cystic Fibrosis Market include AbbVie Inc., Advanced Inhalation Therapies (AIT) Ltd., Alcresta Therapeutics, Inc., AlgiPharma AS, Allergan plc, AstraZeneca plc, Celtaxsys, Inc., Elucigene Diagnostics and La Roche AG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • AlgiPharma AS
  • Allergan plc
  • AstraZeneca plc
  • Celtaxsys, Inc.
  • Elucigene Diagnostics

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of Cystic Fibrosis & improved diagnostic technologies
5.1.1.2. Increasing global awareness for Cystic Fibrosis
5.1.1.3. Research & development activities and robust drug development pipeline
5.1.1.4. Favorable initiatives are taken by NGOs, government, and private companies
5.1.2. Restraints
5.1.2.1. Expiring patents and generic drugs
5.1.2.2. Increase in genetic mutation rate
5.1.3. Opportunities
5.1.3.1. Increasing demand from emerging economies
5.1.3.2. Growing strategic collaborations, merger, and acquisition
5.1.4. Challenges
5.1.4.1. High cost involved in treatment and complicated pathophysiology
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cystic Fibrosis Market, by Route of Administration
6.1. Introduction
6.2. Inhaled Drugs
6.3. Oral Drugs
7. Cystic Fibrosis Market, by Drug Class
7.1. Introduction
7.2. Bronchodilators
7.3. CFTR Modulators
7.4. Mucolytics
7.5. Pancreatic Enzyme Supplements
8. Americas Cystic Fibrosis Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cystic Fibrosis Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Cystic Fibrosis Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AbbVie Inc.
12.2. Advanced Inhalation Therapies (AIT) Ltd.
12.3. Alcresta Therapeutics, Inc.
12.4. AlgiPharma AS
12.5. Allergan plc
12.6. AstraZeneca plc
12.7. Celtaxsys, Inc.
12.8. Elucigene Diagnostics
12.9. F. Hoffmann-La Roche AG
12.10. Galapagos NV
12.11. Gilead Sciences, Inc.
12.12. NovaBiotics Ltd
12.13. Novartis International AG
12.14. Teva Pharmaceutical Industries Ltd
12.15. Vertex Pharmaceuticals, Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CYSTIC FIBROSIS MARKET: DYNAMICS
FIGURE 2. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 12. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. AMERICAS CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 21. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 22. BRAZIL CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. CANADA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. MEXICO CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. CHINA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. INDIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. INDONESIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. JAPAN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. TAIWAN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. THAILAND CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. FRANCE CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. GERMANY CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. ITALY CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. QATAR CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. RUSSIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. SPAIN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL CYSTIC FIBROSIS MARKET: FPNV POSITIONING MATRIX
FIGURE 51. GLOBAL CYSTIC FIBROSIS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 52. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CYSTIC FIBROSIS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CYSTIC FIBROSIS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. AMERICAS CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. BRAZIL CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. CANADA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 39. MEXICO CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. CHINA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. INDIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. INDONESIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. JAPAN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. TAIWAN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. THAILAND CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. FRANCE CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. GERMANY CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. ITALY CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. QATAR CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. RUSSIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. SPAIN CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL CYSTIC FIBROSIS MARKET: SCORES
TABLE 66. GLOBAL CYSTIC FIBROSIS MARKET: BUSINESS STRATEGY
TABLE 67. GLOBAL CYSTIC FIBROSIS MARKET: PRODUCT SATISFACTION
TABLE 68. GLOBAL CYSTIC FIBROSIS MARKET: RANKING
TABLE 69. GLOBAL CYSTIC FIBROSIS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 70. GLOBAL CYSTIC FIBROSIS MARKET: MERGER & ACQUISITION
TABLE 71. GLOBAL CYSTIC FIBROSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 72. GLOBAL CYSTIC FIBROSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 73. GLOBAL CYSTIC FIBROSIS MARKET: INVESTMENT & FUNDING
TABLE 74. GLOBAL CYSTIC FIBROSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 75. GLOBAL CYSTIC FIBROSIS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Advanced Inhalation Therapies (AIT) Ltd.
  • Alcresta Therapeutics, Inc.
  • AlgiPharma AS
  • Allergan plc
  • AstraZeneca plc
  • Celtaxsys, Inc.
  • Elucigene Diagnostics
  • F. Hoffmann-La Roche AG
  • Galapagos NV
  • Gilead Sciences, Inc.
  • NovaBiotics Ltd
  • Novartis International AG
  • Teva Pharmaceutical Industries Ltd
  • Vertex Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...